These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2424961)

  • 1. Enhanced basophil histamine release to concanavalin A in allergic rhinitis.
    Busse WW; Swenson CA; Sharpe G; Koschat M
    J Allergy Clin Immunol; 1986 Jul; 78(1 Pt 1):90-7. PubMed ID: 2424961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma.
    Casolaro V; Spadaro G; Marone G
    Am Rev Respir Dis; 1990 Nov; 142(5):1108-11. PubMed ID: 1700653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma.
    Gaddy JN; Busse WW
    Am Rev Respir Dis; 1986 Nov; 134(5):969-74. PubMed ID: 3096179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The action of strontium on basophil leukocytes and its use to probe the relationship between immunologic stimulus and secretory response.
    Foreman JC; Sobotka AK; Lichtenstein LM
    J Immunol; 1979 Jul; 123(1):153-9. PubMed ID: 87471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the basophil histamine releasability in allergic rhinitis].
    Shen JX
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(2):74-6, 123. PubMed ID: 7692903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of IgE- and non-IgE-mediated histamine release from human basophil leukocytes in vitro by a histamine H1-antagonist, desethoxycarbonyl-loratadine.
    Kleine-Tebbe J; Josties C; Frank G; Stalleicken D; Buschauer A; Schunack W; Kunkel G; Czarnetzki B
    J Allergy Clin Immunol; 1994 Feb; 93(2):494-500. PubMed ID: 7509820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective inhibition of sodium on basophil histamine release in patients with allergic rhinitis and bronchial asthma.
    Tedeschi A; Cottini M; Salmaso C; Milazzo N; Miadonna A
    Eur Respir J; 1996 Oct; 9(10):2070-6. PubMed ID: 8902469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of histamine-releasing factor activity in individual nasal washings: relationship with atopy, basophil response, and membrane-bound IgE.
    Sim TC; Alam R; Forsythe PA; Welter JB; Lett-Brown MA; Grant JA
    J Allergy Clin Immunol; 1992 Jun; 89(6):1157-65. PubMed ID: 1376736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of human basophil activation. III. Impairment of the inhibitory effect of Na+ on IgE-mediated histamine release in patients with allergic rhinitis.
    Beauvais F; Hiéblot C; Burtin C; Benveniste J
    J Allergy Clin Immunol; 1992 Jul; 90(1):52-8. PubMed ID: 1378460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of IgE-dependent basophil releasability in allergic patients.
    Sanz ML; Latasa M; García BE; Gato JJ; Oehling A
    J Investig Allergol Clin Immunol; 1991 Oct; 1(5):293-301. PubMed ID: 1727011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basophil releasability in the newborn: factors limiting immunoglobulin E-mediated histamine release.
    Mendoza GR; Minagawa K; Orner FB; Stiehm ER
    Pediatrics; 1982 Feb; 69(2):188-92. PubMed ID: 6173838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased numbers of circulating basophils with decreased releasability after administration of rhG-CSF to allergic patients.
    Pedersen M; Kristensen KS; Clementsen P; Olsen OT; Skov PS; Permin H; Norn S
    Agents Actions; 1994 Jun; 41 Spec No():C24-5. PubMed ID: 7526647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of IgE on human basophils: relation to serum IgE and anti-IgE-induced histamine release.
    Conroy MC; Adkinson NF; lichtenstein LM
    J Immunol; 1977 Apr; 118(4):1317-21. PubMed ID: 66288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of concanavalin A on human basophils.
    Siraganian RP; Siragania PA
    J Immunol; 1975 Feb; 114(2 pt 2):886-93. PubMed ID: 46257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids.
    Schleimer RP; Derse CP; Friedman B; Gillis S; Plaut M; Lichtenstein LM; MacGlashan DW
    J Immunol; 1989 Aug; 143(4):1310-7. PubMed ID: 2473127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced basophil releasability in subjects infected with human immunodeficiency virus.
    Miadonna A; Leggieri E; Tedeschi A; Lazzarin A; Chianura L; Froldi M; Zanussi C
    Clin Immunol Immunopathol; 1990 Feb; 54(2):237-46. PubMed ID: 1688523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of basophil histamine releasability between atopic and nonatopic asthmatics.
    Son JW; Kim YK; Chung JW; Lee SR; Cho SH; Min KU; Koh YY; Kim YY
    J Korean Med Sci; 1999 Apr; 14(2):153-8. PubMed ID: 10331560
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Kowal K; Bielecki P; DuBuske IV; DuBuske LM
    Allergy Asthma Proc; 2017 May; 38(3):204-215. PubMed ID: 28441991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links.
    MacGlashan DW; Peters SP; Warner J; Lichtenstein LM
    J Immunol; 1986 Mar; 136(6):2231-9. PubMed ID: 2419427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine release from human basophils by synthetic block co-polymers composed of polyoxyethylene and polyoxypropylene and synergy with immunologic and non-immunologic stimuli.
    Atkinson TP; Smith TF; Hunter RL
    J Immunol; 1988 Aug; 141(4):1307-10. PubMed ID: 2456350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.